Jim Simons Immunome Inc. Transaction History

Renaissance Technologies LLC

$63.6 Billion
Q1 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Immunome Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 45,518 shares of IMNM stock, worth $680,038. This represents 0.0% of its overall portfolio holdings.

Number of Shares

45,518

Previous 121,500 62.54%

Holding current value

$680,038

Previous $1.3 Million 13.62%

% of portfolio

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$11.01 - $27.34 $836,561 - $2.08 Million	-75,982 Reduced 62.54%	45,518 $1.12 Million
Q4 2023 Feb 13, 2024	BUY	$7.3 - $10.73 $650,430 - $956,043	89,100 Added 275.0%	121,500 $1.3 Million
Q3 2023 Nov 14, 2023	SELL	$6.17 - $9.16 $74,657 - $110,836	-12,100 Reduced 27.19%	32,400 $271,000
Q2 2023 Aug 11, 2023	BUY	$4.7 - $7.91 $73,320 - $123,396	15,600 Added 53.98%	44,500 $352,000
Q1 2023 May 12, 2023	BUY	$3.26 - $5.69 $25,428 - $44,382	7,800 Added 36.97%	28,900 $144,000

Q4 2022 Feb 13, 2023	SELL	$2.21 - $4.85 $884 - $1,939	-400 Reduced 1.86%	21,100 $47,000
Q2 2022 Aug 12, 2022	BUY	$2.24 - $5.79 $16,800 - $43,425	7,500 Added 53.57%	21,500 $69,000
Q1 2022 May 13, 2022	BUY	$3.88 - $13.99 $54,320 - $195,860	14,000 New	14,000 $80,000
Q3 2021 Nov 12, 2021	SELL	$12.5 - $27.76 $255,000 - $566,304	-20,400 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$16.33 - $32.33 $333,131 - $659,532	20,400 New	20,400 $353,000

Others Institutions Holding IMNM

# of Institutions

106

Shares Held

32.1M

Call Options Held

46.1K

Put Options Held

32.5K

View Full List

About Immunome Inc.

Ticker IMNM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,127,400
Market Cap $181M
Description
Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...

More about IMNM

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account